Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.

Zittoun, R; Audebert, A; Hoerni, B; Bernadou, A; Krulik, M; Rojouan, J; Eghbali, H; Merle-Béral, H; Parlier, Y; Diebold, J

Zittoun, R; Audebert, A; Hoerni, B; Bernadou, A; Krulik, M; Rojouan, J; Eghbali, H; Merle-Béral, H; Parlier, Y; Diebold, J.

J Clin Oncol ; 3(2): 207-14, 1985 Feb.

Article in En | MEDLINE | ID: mdl-3838188

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Hodgkin Disease/radiotherapy; Adolescent; Adult; Aged; Combined Modality Therapy; Female; Hodgkin Disease/drug therapy; Hodgkin Disease/mortality; Humans; Male; Mechlorethamine/administration & dosage; Middle Aged; Neoplasm Staging; Prednisone/administration & dosage; Procarbazine/administration & dosage; Prognosis; Random Allocation; Recurrence; Risk; Time Factors; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1985 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links